Medpace Holdings (MEDP) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips briefly below $100 on Saudi exports, hopes of US-Iran diplomacy
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
Medpace (MEDP) PT Raised to $35.50 at Jefferies; Reiterates Hold
February 28, 2017 9:26 AM ESTJefferies raised its price target on Medpace (NASDAQ: MEDP) to $35.50 (from $34.00) while maintaining a Hold rating. Guidance targets revenue growth of ~7.5% (~8% CC), below consensus' 11.4%. Yet, guidance does bracket Net Income and EPS estimates.
Analyst David Windley commented, "Medpace boasts eye-popping margin,... More
